7.58
price down icon0.79%   -0.06
after-market Handel nachbörslich: 7.58
loading

Cullinan Therapeutics Inc Aktie (CGEM) Neueste Nachrichten

pulisher
06:44 AM

Is Cullinan Therapeutics Inc. meeting your algorithmic filter criteria2025 Dividend Review & Weekly Market Pulse Updates - Newser

06:44 AM
pulisher
05:03 AM

How to track smart money flows in Cullinan Therapeutics Inc.Trade Risk Assessment & Low Volatility Stock Suggestions - Newser

05:03 AM
pulisher
03:52 AM

Will Cullinan Therapeutics Inc. continue its uptrendJuly 2025 WrapUp & Daily Profit Focused Stock Screening - Newser

03:52 AM
pulisher
01:34 AM

Using data models to predict Cullinan Therapeutics Inc. stock movement2025 Earnings Impact & Community Driven Trade Alerts - Newser

01:34 AM
pulisher
01:16 AM

Why Cullinan Therapeutics Inc. stock attracts strong analyst attentionJuly 2025 Highlights & Consistent Growth Stock Picks - Newser

01:16 AM
pulisher
Aug 13, 2025

Insider Sellers Might Regret Selling Cullinan Therapeutics Shares at a Lower Price Than Current Market Value - simplywall.st

Aug 13, 2025
pulisher
Aug 13, 2025

Technical signs of recovery in Cullinan Therapeutics Inc.2025 Major Catalysts & Capital Efficiency Focused Strategies - Newser

Aug 13, 2025
pulisher
Aug 13, 2025

How to build a custom watchlist for Cullinan Therapeutics Inc.July 2025 Volume & Technical Entry and Exit Tips - Newser

Aug 13, 2025
pulisher
Aug 13, 2025

Cullinan Therapeutics Inc. Shows Risk Reward Favoring UpsideEarnings Growth Summary & AI Enhanced Execution Alerts - 선데이타임즈

Aug 13, 2025
pulisher
Aug 13, 2025

Cullinan (CGEM) Q2 R&D Jumps 68% - AOL.com

Aug 13, 2025
pulisher
Aug 13, 2025

Does Cullinan Therapeutics Inc. fit your quant trading modelWeekly Market Outlook & Target Return Focused Stock Picks - Newser

Aug 13, 2025
pulisher
Aug 13, 2025

How Cullinan Therapeutics Inc. stock performs during market volatilityBull Run & Daily Stock Momentum Reports - Newser

Aug 13, 2025
pulisher
Aug 12, 2025

Is Cullinan Therapeutics Inc. stock poised for growthFree Fundamental Winners With Safe Entry Plan - Newser

Aug 12, 2025
pulisher
Aug 12, 2025

Is Cullinan Therapeutics Inc. showing signs of accumulationMonthly Long-Term Market Recap and Summary - Newser

Aug 12, 2025
pulisher
Aug 12, 2025

Full technical analysis of Cullinan Therapeutics Inc. stockFree Swing Trade With Risk Management - Newser

Aug 12, 2025
pulisher
Aug 12, 2025

Cullinan Therapeutics Inc. stock trend outlook and recovery pathProven Trading System with Consistent Gains - Newser

Aug 12, 2025
pulisher
Aug 12, 2025

Market reaction to Cullinan Therapeutics Inc.’s recent newsTechnical Trade Plan with Entry Checklist - Newser

Aug 12, 2025
pulisher
Aug 12, 2025

Is Cullinan Therapeutics Inc. stock reversal real or fakeEntry and Exit Strategy for Swing Traders - Newser

Aug 12, 2025
pulisher
Aug 11, 2025

Clear Street Sees Favorable Read-Through for Cullinan Therapeutics' CLN-978 Trial in SjD Despite Novartis' Positive Phase 3 Results - AInvest

Aug 11, 2025
pulisher
Aug 11, 2025

William Blair Has Pessimistic Outlook of CGEM Q3 Earnings - Defense World

Aug 11, 2025
pulisher
Aug 11, 2025

Can swing trading help recover from Cullinan Therapeutics Inc. lossesEquity Performance Forecast Based on AI Models - Newser

Aug 11, 2025
pulisher
Aug 11, 2025

Key resistance and support levels for Cullinan Therapeutics Inc.Free Value Investing Picks With Stability - Newser

Aug 11, 2025
pulisher
Aug 09, 2025

Using Ichimoku Cloud for Cullinan Therapeutics Inc. technicalsDay Trading Setup and Momentum Analysis - Newser

Aug 09, 2025
pulisher
Aug 08, 2025

Cullinan Therapeutics: Q2 Earnings Snapshot - Greenwich Time

Aug 08, 2025
pulisher
Aug 08, 2025

Cullinan Therapeutics Reports Q2 2025 Financial Results - TipRanks

Aug 08, 2025
pulisher
Aug 07, 2025

What to expect from Cullinan Therapeutics Inc. in the next 30 daysPrice Movement and Market Sentiment Analysis - Newser

Aug 07, 2025
pulisher
Aug 07, 2025

Cullinan Therapeutics Inc reports results for the quarter ended June 30Earnings Summary - TradingView

Aug 07, 2025
pulisher
Aug 07, 2025

Cullinan Therapeutics reports Q2 EPS ($1.07), consensus (86c) - TipRanks

Aug 07, 2025
pulisher
Aug 07, 2025

Cullinan Therapeutics, Inc. Announces Board Changes, Effective August 7, 2025 - MarketScreener

Aug 07, 2025
pulisher
Aug 07, 2025

Cullinan Therapeutics Reports Wider-Than-Expected Q2 LossNews and Statistics - IndexBox

Aug 07, 2025
pulisher
Aug 07, 2025

Cullinan Therapeutics (CGEM) to Release Earnings on Thursday - Defense World

Aug 07, 2025
pulisher
Aug 07, 2025

Cullinan Management Appoints New Board Members - TipRanks

Aug 07, 2025
pulisher
Aug 07, 2025

Cullinan Therapeutics Q2 net loss widens to $70.1 mln on higher R&D costs - MarketScreener

Aug 07, 2025
$36.50
price up icon 0.11%
$86.16
price up icon 0.36%
$26.45
price down icon 1.56%
$127.75
price up icon 3.97%
$112.70
price down icon 0.07%
biotechnology ONC
$309.69
price up icon 0.71%
Kapitalisierung:     |  Volumen (24h):